CA17129 – Catalysing transcriptomics research in cardiovascular disease
CardioRNA COST Action CA17129 is a collaborative pan-European network of multidisciplinary researchers, clinicians, and industrial partners aiming to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.
Check out our WG2-lead consensus guidelines manuscript, out now in Molecular TherapyJanuary 11, 2022
Check out our WG2-lead manuscript ‘Consensus guidelines for the validation of quantitative RT-qPCR assays in clinical research by the CardioRNA consortium’ out now in Molecular Therapy. This is a major deliverable of WG2. Congratulations to David de Gonzalo-Calvo and team.
Open Postdoc positions in Cardiology at the University of Colorado Anschutz Medical CampusDecember 11, 2021
A fully funded Postdoctoral Fellow position is available in the Division of Cardiology in the laboratory of Dr. Timothy McKinsey in the Department of Medicine at the University of Colorado School of Medicine. Our lab is focused on understanding the signaling and gene regulatory mechanisms that control heart failure and associated disorders and is particularly […]
Postdoctoral opportunity at the Centre for Cardiovascular Science, University of Edinburgh, UKDecember 11, 2021
A fantastic opportunity for a postdoctoral fellow for a 4 year British Heart Foundation-funded position in the Baker lab within the Centre for Cardiovascular Science at the University of Edinburgh to work on long non-coding RNAs in endothelial cells and angiogenesis. Please see here for full details and how to apply. The Centre for Cardiovascular […]